+499.5%
MRNA vs VTRS
+66.3%
+433.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VTRS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.9% | -2.0% |
| 7D | +5.5% | +3.3% | +2.2% | +3.3% |
| 30D | +158.7% | -3.6% | +162.4% | +163.8% |
| 3M | +182.1% | +7.0% | +175.2% | +171.3% |
| 6M | +151.8% | +17.5% | +134.4% | +125.7% |
| YTD | +393.6% | +38.8% | +354.8% | +279.6% |
| 1Y | +499.5% | +69.2% | +430.3% | +296.9% |
| All | +499.5% | +66.3% | +433.2% | +296.9% |
Cumulative growth
Daily Returns
Daily percentage return beside VTRS.
Daily Out/Under-Performance
Portfolio return minus VTRS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VTRS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VTRS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling